Digital Therapeutics Market Overview
The report is titled as ‘Digital Therapeutics Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Digital Therapeutics market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.
Reports & Insights Overview
The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Digital Therapeutics market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Digital Therapeutics Market Segmentation
The digital therapeutics market is segmented on the basis of application, product, sales channel, and region.
By Application
Preventive Applications
Prediabetes
Obesity
Nutrition
Lifestyle Management
Other Preventive Applications
Treatment/Care-related Applications
Diabetes
CNS Disorders
Mental Health Disorder
Other CNS Disorders
Chronic Respiratory Disorders
Musculoskeletal Disorders
Cardiovascular Diseases
Smoking Cessation
Medication Adherence
Gastrointestinal Disorders
Substance Use & Addiction Management
Rehabilitation & Patient Care
Other Treatment/Care-related Applications
By Product
Device
Software
Services
By Sales Channel
Patient
Caregiver
Providers
Payer
Employer
Pharma
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Digital Therapeutics Market Key Players
Some of the key participating players in Digital Therapeutics market are:
Noom
Livongo Health
WellDoc
Pear Therapeutics
Proteus Digital Health
Propeller Health
Akili Interactive Labs
Better Therapeutics
Happify
Kaia Health
Mango Health
Click Therapeutics
Canary Health
Wellthy Therapeutics
Cognoa
Ayogo Health
Mindstrong Health
2Morrow
Ginger
BehaVR
Mindable Health
Virta Health
Hinge Health
Doktor.se
Toshiba America Business Solutions Inc.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product developments and launches
Global Healthcare Industry Outlook
Digital Therapeutics Adoption Rate, by End User
Top Companies Historical Growth Rate
Pricing Impact
Impact of Regulations
Advantages of Digital Therapeutics
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.
To learn more about this report, request a free sample copy
1. Report Overview/Executive Summary
1.1. Global Digital Therapeutics Market Report Overview
1.2. Introduction
1.3. Report Description
1.4. Methodology
2. Introduction to the Global Digital Therapeutics Market
2.1. Introduction
2.1.1. Introduction
2.1.2. Market Taxonomy
2.2. Global Digital Therapeutics Market Snapshot
2.3. Global Digital Therapeutics Market Size and Forecast, 2018–2028
2.3.1. Introduction
2.3.2. Market Value Forecast and Y-0-Y Growth Rate (2018–2028)
2.4. Global Digital Therapeutics Market Dynamics
2.4.1. Drivers
2.4.2. Restraints
2.4.3. Opportunity
2.4.4. Trends
2.5. Key Regulations
2.6. Pest Analysis
3. Global Digital Therapeutics Market, By Application
3.1. Introduction
3.1.1. AGR% Comparison, By Application
3.1.2. BPS Analysis, By Application
3.1.3. Market Revenue Forecast, By Application
3.2. Diabetes
3.2.1. Market Revenue Forecast US$, 2018–2028
3.3. Obesity
3.3.1. Market Revenue Forecast US$, 2018–2028
3.4. Cardiovascular Disease
3.4.1. Market Revenue Forecast US$, 2018–2028
3.5. Central Nervous System Disorder
3.5.1. Market Revenue Forecast US$, 2018–2028
3.6. Respiratory
3.6.1. Market Revenue Forecast US$, 2018–2028
3.7. Other
3.7.1. Market Revenue Forecast US$, 2018–2028
3.8. Global Digital Therapeutics Market Attractiveness Index, By Application
4. Global Digital Therapeutics Market, By End Use
4.1. Introduction
4.1.1. AGR% Comparison, By End Use
4.1.2. BPS Analysis, By End Use
4.1.3. Market Revenue Forecast, By End Use
4.2. Patients
4.2.1. Market Revenue Forecast US$, 2018–2028
4.3. Caregivers
4.3.1. Market Revenue Forecast US$, 2018–2028
4.4. Emloyers
4.4.1. Market Revenue Forecast US$, 2018–2028
4.5. Players
4.5.1. Market Revenue Forecast US$, 2018–2028
4.6. Pharmaceutical Companies
4.6.1. Market Revenue Forecast US$, 2018–2028
4.7. Global Digital Therapeutics Market Attractiveness Index, By End Use
5. Global Digital Therapeutics Market, By Region
5.1. Introduction
5.1.1. AGR% Comparison, By Region
5.1.2. BPS Analysis, By Region
5.1.3. Market Revenue Forecast, By Region
5.2. North America
5.2.1. Market Revenue Forecast US$, 2018–2028
5.3. Latin America
5.3.1. Market Revenue Forecast US$, 2018–2028
5.4. Europe
5.4.1. Market Revenue Forecast US$, 2018–2028
5.5. Asia Pacific
5.5.1. Market Revenue Forecast US$, 2018–2028
5.6. Middle East and Africa
5.6.1. Market Revenue Forecast US$, 2018–2028
5.7. Global Digital Therapeutics Market Attractiveness Index, By Region
6. North America Digital Therapeutics MarketAnalysis and Forecast, 2018–2028
6.1. Introduction
6.1.1. AGR% Comparison, By Country
6.1.2. BPS Analysis, By Country
6.1.3. Market Revenue Forecast, By Country
6.2. U.S. Digital Therapeutics Market
6.2.1. Market Revenue Forecast US$, 2018–2028
6.3. Canada Digital Therapeutics Market
6.3.1. Market Revenue Forecast US$, 2018–2028
6.4. North America Digital Therapeutics Market, By Application
6.4.1. Diabetes
6.4.1.1. Market Revenue Forecast US$, 2018–2028
6.4.2. Obesity
6.4.2.1. Market Revenue Forecast US$, 2018–2028
6.4.3. Cardiovascular Disease
6.4.3.1. Market Revenue Forecast US$, 2018–2028
6.4.4. Central Nervous System Disorder
6.4.4.1. Market Revenue Forecast US$, 2018–2028
6.4.5. Respiratory
6.4.5.1. Market Revenue Forecast US$, 2018–2028
6.4.6. Other
6.4.6.1. Market Revenue Forecast US$, 2018–2028
6.5. North America Digital Therapeutics Market, By End Use
6.5.1. Patients
6.5.1.1. Market Revenue Forecast US$, 2018–2028
6.5.2. Caregivers
6.5.2.1. Market Revenue Forecast US$, 2018–2028
6.5.3. Emloyers
6.5.3.1. Market Revenue Forecast US$, 2018–2028
6.5.4. Players
6.5.4.1. Market Revenue Forecast US$, 2018–2028
6.5.5. Pharmaceutical Companies
6.5.5.1.1. Market Revenue Forecast US$, 2018–2028
6.6. North America Digital Therapeutics Market Attractiveness Index
6.6.1. By Country
6.6.2. By Application
6.6.3. By End Use
7. Latin America Digital Therapeutics Market Analysis and Forecast, 2018–2028
7.1. Introduction
7.1.1. AGR% Comparison, By Country
7.1.2. BPS Analysis, By Country
7.1.3. Market Revenue Forecast, By Country
7.2. Brazil Digital Therapeutics Market
7.2.1. Market Revenue Forecast US$, 2018–2028
7.3. Mexico Digital Therapeutics Market
7.3.1. Market Revenue Forecast US$, 2018–2028
7.4. Rest of Latin America Digital Therapeutics Market
7.4.1. Market Revenue Forecast US$, 2018–2028
7.5. Latin America Digital Therapeutics Market, By Application
7.5.1. Diabetes
7.5.1.1. Market Revenue Forecast US$, 2018–2028
7.5.2. Obesity
7.5.2.1. Market Revenue Forecast US$, 2018–2028
7.5.3. Cardiovascular Disease
7.5.3.1. Market Revenue Forecast US$, 2018–2028
7.5.4. Central Nervous System Disorder
7.5.4.1. Market Revenue Forecast US$, 2018–2028
7.5.5. Respiratory
7.5.5.1. Market Revenue Forecast US$, 2018–2028
7.5.6. Other
7.5.6.1. Market Revenue Forecast US$, 2018–2028
7.6. Latin America Digital Therapeutics Market, By End Use
7.6.1. Patients
7.6.1.1. Market Revenue Forecast US$, 2018–2028
7.6.2. Caregivers
7.6.2.1. Market Revenue Forecast US$, 2018–2028
7.6.3. Emloyers
7.6.3.1. Market Revenue Forecast US$, 2018–2028
7.6.4. Players
7.6.4.1. Market Revenue Forecast US$, 2018–2028
7.6.5. Pharmaceutical Companies
7.6.5.1. Market Revenue Forecast US$, 2018–2028
7.7. Latin America Digital Therapeutics Market Attractiveness Index
7.7.1. By Country
7.7.2. By Application
7.7.3. By End Use
8. Europe Digital Therapeutics MarketAnalysis and Forecast, 2018–2028
8.1. Introduction
8.1.1. AGR% Comparison, By Country
8.1.2. BPS Analysis, By Country
8.1.3. Market Revenue Forecast, By Country
8.2. U.K. Digital Therapeutics Market
8.2.1. Market Revenue Forecast US$, 2018–2028
8.3. France Digital Therapeutics Market
8.3.1. Market Revenue Forecast US$, 2018–2028
8.4. Germany Digital Therapeutics Market
8.4.1. Market Revenue Forecast US$, 2018–2028
8.5. Italy Digital Therapeutics Market
8.5.1. Market Revenue Forecast US$, 2018–2028
8.6. Spain Digital Therapeutics Market
8.6.1. Market Revenue Forecast US$, 2018–2028
8.7. Russia Digital Therapeutics Market
8.7.1. Market Revenue Forecast US$, 2018–2028
8.8. Rest of Europe Digital Therapeutics Market
8.8.1. Market Revenue Forecast US$, 2018–2028
8.9. Europe Digital Therapeutics Market, By Application
8.9.1. Diabetes
8.9.1.1. Market Revenue Forecast US$, 2018–2028
8.9.2. Obesity
8.9.2.1. Market Revenue Forecast US$, 2018–2028
8.9.3. Cardiovascular Disease
8.9.3.1. Market Revenue Forecast US$, 2018–2028
8.9.4. Central Nervous System Disorder
8.9.4.1. Market Revenue Forecast US$, 2018–2028
8.9.5. Respiratory
8.9.5.1. Market Revenue Forecast US$, 2018–2028
8.9.6. Other
8.9.6.1. Market Revenue Forecast US$, 2018–2028
8.10. Europe Digital Therapeutics Market, By End Use
8.10.1. Patients
8.10.1.1. Market Revenue Forecast US$, 2018–2028
8.10.2. Caregivers
8.10.2.1. Market Revenue Forecast US$, 2018–2028
8.10.3. Emloyers
8.10.3.1. Market Revenue Forecast US$, 2018–2028
8.10.4. Players
8.10.4.1. Market Revenue Forecast US$, 2018–2028
8.10.5. Pharmaceutical Companies
8.10.5.1. Market Revenue Forecast US$, 2018–2028
8.11. Europe Digital Therapeutics Market Attractiveness Index
8.11.1. By Country
8.11.2. By Application
8.11.3. By End Use
9. Asia Pacific Digital Therapeutics Market Analysis and Forecast, 2018–2028
9.1. Introduction
9.1.1. AGR% Comparison, By Country
9.1.2. BPS Analysis, By Country
9.1.3. Market Revenue Forecast, By Country
9.2. China Digital Therapeutics Market
9.2.1. Market Revenue Forecast US$, 2018–2028
9.3. India Digital Therapeutics Market
9.3.1. Market Revenue Forecast US$, 2018–2028
9.4. Japan Digital Therapeutics Market
9.4.1. Market Revenue Forecast US$, 2018–2028
9.5. Australia and New Zealand Digital Therapeutics Market
9.5.1. Market Revenue Forecast US$, 2018–2028
9.6. ASEAN Digital Therapeutics Market
9.6.1. Market Revenue Forecast US$, 2018–2028
9.7. Rest of Asia Pacific Digital Therapeutics Market
9.7.1. Market Revenue Forecast US$, 2018–2028
9.8. Asia Pacific Digital Therapeutics Market, By Application
9.8.1. Diabetes
9.8.1.1. Market Revenue Forecast US$, 2018–2028
9.8.2. Obesity
9.8.2.1. Market Revenue Forecast US$, 2018–2028
9.8.3. Cardiovascular Disease
9.8.3.1. Market Revenue Forecast US$, 2018–2028
9.8.4. Central Nervous System Disorder
9.8.4.1. Market Revenue Forecast US$, 2018–2028
9.8.5. Respiratory
9.8.5.1. Market Revenue Forecast US$, 2018–2028
9.8.6. Other
9.8.6.1. Market Revenue Forecast US$, 2018–2028
9.9. Asia Pacific Digital Therapeutics Market, By End Use
9.9.1. Patients
9.9.1.1. Market Revenue Forecast US$, 2018–2028
9.9.2. Caregivers
9.9.2.1. Market Revenue Forecast US$, 2018–2028
9.9.3. Emloyers
9.9.3.1. Market Revenue Forecast US$, 2018–2028
9.9.4. Players
9.9.4.1. Market Revenue Forecast US$, 2018–2028
9.9.5. Pharmaceutical Companies
9.9.5.1. Market Revenue Forecast US$, 2018–2028
9.10. Asia Pacific Digital Therapeutics Market Attractiveness Index
9.10.1. By Country
9.10.2. By Application
9.10.3. By End Use
10. Middle East and Africa Digital Therapeutics Market, By Region
10.1. Introduction
10.1.1. AGR% Comparison, By Country
10.1.2. BPS Analysis, By Country
10.1.3. Market Revenue Forecast, By Country
10.2. GCC Countries Digital Therapeutics Market
10.2.1. Market Revenue Forecast US$, 2018–2028
10.3. South Africa Digital Therapeutics Market
10.3.1. Market Revenue Forecast US$, 2018–2028
10.4. North Africa Digital Therapeutics Market
10.4.1. Market Revenue Forecast US$, 2018–2028
10.5. Middle East and Africa Digital Therapeutics Market, By Application
10.5.1. Diabetes
10.5.1.1. Market Revenue Forecast US$, 2018–2028
10.5.2. Obesity
10.5.2.1. Market Revenue Forecast US$, 2018–2028
10.5.3. Cardiovascular Disease
10.5.3.1. Market Revenue Forecast US$, 2018–2028
10.5.4. Central Nervous System Disorder
10.5.4.1. Market Revenue Forecast US$, 2018–2028
10.5.5. Respiratory
10.5.5.1. Market Revenue Forecast US$, 2018–2028
10.5.6. Other
10.5.6.1. Market Revenue Forecast US$, 2018–2028
10.6. Middle East and Africa Digital Therapeutics Market, By End Use
10.6.1. Patients
10.6.1.1. Market Revenue Forecast US$, 2018–2028
10.6.2. Caregivers
10.6.2.1. Market Revenue Forecast US$, 2018–2028
10.6.3. Emloyers
10.6.3.1. Market Revenue Forecast US$, 2018–2028
10.6.4. Players
10.6.4.1. Market Revenue Forecast US$, 2018–2028
10.6.5. Pharmaceutical Companies
10.6.5.1. Market Revenue Forecast US$, 2018–2028
10.7. Middle East and Africa Digital Therapeutics Market Attractiveness Index
10.7.1. By Country/Region
10.7.2. By Application
10.7.3. By End Use
11. Competitive Landscape
11.1. Company Profiles
11.1.1. Apria Healthcare Group
11.1.1.1. Company Overview
11.1.1.2. Financial Overview
11.1.1.3. Product Portfolio
11.1.1.4. Key Developments
11.1.1.5. Business Strategies
11.1.2. Omada Health
11.1.3. Canary Health
11.1.4. Noom Health
11.1.5. Livongo Health
11.1.6. WellDoc Inc.
11.1.7. Propeller Health
11.1.8. Evolent Health
11.1.9. Doximity
11.1.10. Perfint Healthcare
11.1.11. Proteus Digital Health
11.1.12. Nanobiosym
11.1.13. Zest Health
12. Conclusion
13. Acronyms
The global digital therapeutics market in 2020 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ 22.9 Bn by 2028 with a significant CAGR of 25.8%.
The base year for the report is 2021 in digital therapeutics market.
The digital therapeutics market is segmented on the basis of application, end-use, and region
The global digital therapeutics market is mainly dominated by Omada Health, NeuroTrack Technologies, Inc., ZappRx, MEDIMETRICS, Arthro Therapeutics, BiogeniQ, Oviva AG, Healark, Pathology Diagnostics Ltd., between MD, LLC.
